Načítá se...
Engineering Botulinum Toxins to Improve and Expand Targeting and SNARE Cleavage Activity
Botulinum neurotoxins (BoNTs) are highly successful protein therapeutics. Over 40 naturally occurring BoNTs have been described thus far and, of those, only 2 are commercially available for clinical use. Different members of the BoNT family present different biological properties but share a similar...
Uloženo v:
| Vydáno v: | Toxins (Basel) |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6071219/ https://ncbi.nlm.nih.gov/pubmed/29973505 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/toxins10070278 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|